We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Final Rule Puts Pharma Patent Agreements Under the Microscope
FTC Final Rule Puts Pharma Patent Agreements Under the Microscope
November 11, 2013
Drugmakers will soon have to seek Federal Trade Commission antitrust review for all proposed licensing agreements for “exclusive” patent rights.